Thrivent Financial for Lutherans’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,059
| Closed | -$8K | – | 2511 |
|
|
2022
Q4 | $8K | Hold |
3,059
| – | – | ﹤0.01% | 2405 |
|
|
2022
Q3 | $12K | Hold |
3,059
| – | – | ﹤0.01% | 2399 |
|
|
2022
Q2 | $21K | Sell |
3,059
-591
| -16% | -$4.06K | ﹤0.01% | 2402 |
|
|
2022
Q1 | $42K | Hold |
3,650
| – | – | ﹤0.01% | 2488 |
|
|
2021
Q4 | $67K | Sell |
3,650
-349
| -9% | -$6.41K | ﹤0.01% | 2449 |
|
|
2021
Q3 | $101K | Buy |
3,999
+672
| +20% | +$17K | ﹤0.01% | 2452 |
|
|
2021
Q2 | $211K | Buy |
+3,327
| New | +$211K | ﹤0.01% | 2405 |
|